The global cytotoxic drugs market is estimated to grow at a significant CAGR during the forecast period. A huge increase in cancer rates and more awareness about cancer disorders are two important reasons driving the market’s growth. According to the WHO, cancer is the second leading cause of death globally, which accounted for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women.
The cancer burden continues to grow globally, exerting tremendous physical, emotional, and financial strain on individuals, families, communities, and health systems. Many health systems in low- and middle-income countries are least prepared to manage this burden, and large numbers of cancer patients globally, do not have access to timely quality diagnosis and treatment. In countries where health systems are strong, survival rates of many types of cancers are improving, thanks to accessible early detection, quality treatment, and survivorship care.
The global cytotoxic drugs market is classified based on drug class and application. Based on drug class, the market is classified into alkylating, antimetabolites, antitumor antibiotics, plant alkaloids, and others. Based on application, the market is classified into lung cancer, breast cancer, prostate cancer, pancreatic cancer, and others.
Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America is estimated to witness significant growth during the forecast period, owing to the rising incidences of cancer and significant funding opportunity for cancer researchers in the region.
The major players operating in the market include Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. To maintain a strong position in the market, these market players adopt various strategies such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in June 2019, Pfizer Inc. acquired Array BioPharma Inc., a commercial-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of targeted small molecule drugs, for the treatment of cancer and other diseases.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cytotoxic-drugs-market-share
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2022-2030
- Segment Covered- By Drug Class, By Application
- Competitive Landscape: Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. among others.
Cytotoxic Drugs Market- Segmentation
By Drug Class
- Alkylating
- Antimetabolites
- Antitumor Antibiotics
- Plant Alkaloids
- Others
By Application
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Pancreatic Cancer
- Others
A full report of Cytotoxic Drugs Market is available at: https://www.omrglobal.com/industry-reports/cytotoxic-drugs-market-share
Cytotoxic Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Mylan N.V.
- Johnson & Johnson Services, Inc.
- Hoffman La-Roche AG
- Bristol Myers Squibb Co.
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
